This content is machine translated Multiple sclerosis Personalized medicine at the cutting edge Intensive research in the field of multiple sclerosis (MS) has led to the availability of different treatment options – depending on the form of the disease and its severity. This…
View Post 4 min This content is machine translated ECTRIMS Congress in Berlin International MS experts provided an update on research and therapy How can Big Data be used in the field of multiple sclerosis? And what’s the latest on existing treatment options? The ECTRIMS congress in Berlin clarified.
View Post 7 min This content is machine translated ECTRIMS/ACTRIMS in Paris MS in children – Does the same apply to therapy as in adults? At the ECTRIMS/ACTRIMS Congress, for once the pediatric population came into focus. Fingolimod was shown to be effective here as well. But the benefits don’t come “free.”
View Post 5 min This content is machine translated "Time is brain" also applies to MS Treatment as early as possible improves prognosis in multiple sclerosis In recent years, the treatment of multiple sclerosis (MS) has changed dramatically: Various new agents have come onto the market that improve the prognosis of many MS patients and enhance…
View Post 3 min This content is machine translated Decrease of brain volume in multiple sclerosis Potential future parameter for therapy monitoring More and more is becoming known about the importance of decreasing brain volume in patients with multiple sclerosis. And this is not least thanks to steady progress in imaging techniques…
View Post 6 min This content is machine translated Highlights from the ECTRIMS Congress 2013 New therapeutic approaches and an exciting hypothesis on the pathogenesis From October 2-5, 2013, the 29th ECTRIMS (Congress of the European Committee for Research and Treatment in Multiple Sclerosis) and the 18th RIMS (Annual Conference of Rehabilitation in MS) were…
View Post 8 min This content is machine translated Immunotherapy and immunomodulation Disease-modifying therapies for multiple sclerosis. Multiple sclerosis is the most common neurological disease in young adults. Already at a young age it can lead to permanent disability, but the disease activity at the beginning of…
View Post 5 min This content is machine translated Rehabilitation and long-term management in MS Are rehabilitative measures still necessary in MS today? Despite the introduction of disease-modulating pharmacological therapies, rehabilitative interventions continue to play an important role in the long-term management of MS. People with MS should be encouraged to engage in…
